China Pharmaceutical Glass Packaging Industry Report 2013-2016

April 4, 2014

ChinaMarketResearchReports.com adds Research Report on “China Pharmaceutical Glass Packaging Industry Report, 2013-2016″ to its store.

DALLAS, April 4, 2014 /PRNewswire-iReach/ — Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly. In 2013, China’s pharmaceutical glass bottle market capacity amounted to 80 billion pieces with the weight of 250,000-300,000 tons.

(Photo: http://photos.prnewswire.com/prnh/20140404/MN98397)

Due to low entry barriers, Chinese pharmaceutical glass market is featured with serious overcapacity of medium and low-end products as well as the reliance of high-end products on imports. At present, developed countries prefer first-class waterproof neutral borosilicate glass, while China still in the main applies low borosilicate glass, sodium-calcium glass and “semi-neutral borosilicate glass” (its chemical stability cannot meet neutral requirements; the heavy metal content in glass is not defined clearly; dimensions are not accurate). As for prefilled injection system glass, China mainly relies on the import from foreign brands such as German Schott.

Order a copy of this report at http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114772 .

The report involves the following:

    --  Market size, market demand, competition pattern, import & export and
        development trend of China pharmaceutical glass industry;
    --  Status quo, competition pattern and price analysis of China prefilled
        syringe industry;
    --  Operation, pharmaceutical glass business and development prospects of
        four global and six Chinese pharmaceutical glass packaging enterprises.

After years of development and competition, Chinese pharmaceutical glass market concentration degree is still not high, but there have been competitive leading players in some market segments mainly in Jiangsu, Zhejiang and Shandong.

Shandong Pharmaceutical Glass is the world’s fifth and China’s first medical glass (Class-I) producer. As one of top five Chinese prefilled syringe suppliers, Shandong Pharmaceutical Glass has the capacity of 50 million units/a, but it is still exploring the market with a rather low market share. Meanwhile, the company is a leading pharmaceutical molded bottle enterprise in China with the capacity of 10 billion units/a and about 70% market share.

Weigao is also one of the top five Chinese prefilled syringe suppliers. By virtue of preemptive advantages and perfect sales networks, Weigao sold 70 million prefilled syringes in 2013, holding about 60% market share in China.

German Schott has transferred from simple high-end pharmaceutical glass raw material supply to the combination of raw material supply and joint production of finished products. Its joint venture in China — Schott Xin Kang Pharmaceutical Packaging Co., Ltd. can produce 1-1.5 billion pharmaceutical glass bottles (vials and ampule bottles) each year.

Germany Gerresheimerd conducts Plastic Systems, Moulded Glass, Tubular Glass and Life Science Research in China. However, the prefilled syringes from the company in China are not made in China but imported. In addition, Gerresheimerd and Shuangfeng Glass founded a high-end medical packaging material joint venture — Gerresheimer Shuangfeng that has two subsidiaries located in Danyang city and Zhenjiang city, as well as three production sites (two in Danyang and one in Zhenjiang).

Comprehensive Table of Contents and more for the report “China Pharmaceutical Glass Packaging Industry Report, 2013-2016″ is available at http://www.chinamarketresearchreports.com/114772.html .

Few Points from Table of Contents

List of Charts

Classification and Application of Pharmaceutical Glass

New-type Pharmaceutical Glass Packaging and Application

Pharmaceutical Glass Packaging Industry Chain

Output of Human Powder (Including Lyophiled Powder) and Injection in China, 2010-2013

China’s Human LVP Output, 2010-2013

Revenue and YoY Growth Rate of Chinese Veterinary Drug industry, 2007-2013

China’s Glass Ampule Import and Export Volume, 2011-2013

China’s Glass Ampule Import and Export Value, 2011-2013

China’s Glass Ampule Import and Export Average Price, 2011-2013

Prefilled Syringe-use Materials

Prefilled Syringe Classification and Structure

Chinese Prefilled Syringe Suppliers and Their Products

Major Chinese Prefilled Enterprises and Their Capacity, 2013

Prices of Some Chinese Prefilled Pharmaceutical Packaging Products, 2010-2013

BD’s Main Businesses

BD’s Revenue and Operating Profit, FY2010-FY2013

BD’s Revenue Structure (by Business), FY2012-FY2013

BD’s Revenue Structure (by Region), FY2012-FY2013

BD’s Medical Revenue (by Product), FY2011-FY2013

Gerresheimer’s Revenue Structure (by Consumer Market), 2012

Gerresheimer’s Revenue and Operating Profit, 2009-2013

Gerresheimer’s Revenue (by Business), 2009-2013

Gerresheimer’s Revenue Structure (by Region), 2012

Schott’s Subsidiaries in China

Nipro’s Revenue and Net Income, FY2010-FY2013

Nipro’s Revenue Structure (by Business), FY2012-FY2013

Nipro’s Revenue Structure (by Region), FY2013

Nipro’s Glassware Revenue and % in Total Revenue, FY2012-FY2013

Nipro’s Main Subsidiaries and Business in China

Main Products of Shandong Pharmaceutical Glass

Revenue and Net Income of Shandong Pharmaceutical Glass, 2008-2013

Operating Revenue of Shandong Pharmaceutical Glass (by Product), 2008-2013

Operating Revenue of Shandong Pharmaceutical Glass (by Region), 2008-2013

Gross Margin of Shandong Pharmaceutical Glass (by Product), 2008-2013

Revenue and Gross Margin of Shandong Pharmaceutical Glass (by Product), 2012-2016E

Weigao’s Product Categories and Major Products

Weigao’s Revenue and Net Income, 2009-2013

Weigao’s Sales and Distribution Network, 2012

Output of Weigao’s Main Products, 2011-2013

Weigao’s Revenue Structure (by Product), 2009-2013

Revenue Structure of Weigao’s Regular Medical Supplies, 2006-2013

Main High-value-added Products of Weigao’s Regular Medical Supplies

Weigao’s Revenue (by Region), 2008-2013

Weigao’s Prefilled Syringe Output and Sales Revenue, 2011-2013

Browse more reports on Life Sciences Industry at http://www.chinamarketresearchreports.com/cat/life-sciences.html .

About Us:

China Market Research Reports is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details on sales@chinamarketresearchreports.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need.

Media Contact: Priyank Tiwari, China Market Research Reports, + 1 888 391 5441, sales@chinamarketresearchreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE China Market Research Reports

Source: PR Newswire

comments powered by Disqus